Clinical Outcomes of Early Phenotype-Desirable Antimicrobial Therapy for Enterobacterales Bacteremia
Rena C. Moon, Shawn H. MacVane, Joy David, Jacob B. Morton, Ning Rosenthal, Kimberly C. Claeys · 2024
Read Clinical Outcomes of Early Phenotype-Desirable Antimicrobial Therapy for Enterobacterales Bacteremia by Rena C. Moon, Shawn H. MacVane, Joy David, Jacob B. Morton, Ning Rosenthal, Kimberly C. Claeys (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11667351.txt.
Description
Rena Moon and five co-authors compare early versus later targeted antibiotic use in blood infections in a 2024 study. For these infections, fast effective care aids survival, and stewardship favors the narrowest drug that still works against the germ's traits. The team ask whether giving that tailored drug in the first two days beats giving it later.
They draw on a large hospital database in the United States with more than eight thousand eligible patients. After adjusting for illness burden, patients who got the tailored drug early were less likely to return to hospital within a month. Ranked overall outcomes are also reported in the study that follows.
Catalog record
| CREATOR | Rena C. Moon, Shawn H. MacVane, Joy David, Jacob B. Morton, Ning Rosenthal, Kimberly C. Claeys |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |